UCLA research highlights delayed Huntington’s disease diagnosis for Black patients

FHS
July 10, 2024
3:56 am

New research led by UCLA Health revealed that Black patients with Huntington’s disease in the U.S. and Canada received their diagnoses, on average, one year later compared to White patients after symptoms first appear.

Invitation to MorphoSys’ Full Year Results 2023 Conference Call on March 14, 2024 – Biotech Investments

EQS-News: MorphoSys AG / Key word(s): Annual Results Invitation to MorphoSys’ Full Year Results 2023 Conference Call on March 14, 2024 07.03.2024 / 22:03 CET/CEST

March 8, 2024

Substituting dairy with whole grains and olive oil lowers non-communicable disease risk

Review and meta-analysis published in Current Developments in Nutrition examined long-term dietary associations of dairy products and non-communicable diseases (NCDs), finding no significant change in

May 22, 2024

Guselkumab Shows Early Symptom Improvement in UC

New data from the QUASAR phase III induction study presented at the American College of Gastroenterology (ACG) annual meeting demonstrated early symptom improvement with guselkumab

November 8, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.